TABLE 3.
Sample | nt change | aa change | SNP (%)a | Clinical sequencesb |
||
---|---|---|---|---|---|---|
Total UK (no.) | Last 28 days England (no.) | Date of first detection | ||||
13-Oct-20 | A22994G | T478A | 7.8, 7.6 | |||
A23201G | T547A | 7.8 | 1 | 0 | 23-10-20 | |
G23282T | D574Y | 99.4, 44.4 | 400 | 5 | 30-03-20 | |
10-Nov-20 | T21710C | S50P | 8.4 | |||
T21765C | I68T | 12.1 | 19 | 0 | 10-04-20 | |
C21846T | T95I | 7.8 | 456 | 141 | 22-03-20 | |
C21855T | S98F | 70.1, 14.5 | 1,672 | 281 | 22-03-20 | |
C21867A | R102K | 6.5 | ||||
C22995G | T478R | 18.3 | 22 | 0 | 19-10-20 | |
T23105C | F515L | 6.5 | 1 | 0 | 01-01-21 | |
G23282T | D574Y | 33.1, 14.2 | 400 | 5 | 30-03-20 | |
8-Dec-20 | C21727T | S56F | 10.0 | |||
A21894G | D111G | 11.8 | ||||
T21990C | V143A | 5.1 | ||||
T23031C | F490S | 7.3 | 100 | 50 | 05-04-20 | |
T23075C | Y505H | 8.2 | 9 | 4 | 02-11-20 | |
12-Jan-21 | A21683G | K41E | 18.2 | 2 | 0 | 27-11-21 |
T21723C | L54S | 5.1 | 1 | 0 | 29-01-21 | |
G21761T | A67S | 99.6 | 149 | 28 | 19-04-20 | |
A21779G | T73A | 16.3 | 4 | 2 | 16-10-20 | |
C21855T | S98F | 6.0, 48.0 | 1,672 | 281 | 22-03-20 | |
T21861C | I100T | 31.9 | 15 | 0 | 27-03-20 | |
26-Jan-21 | T21831C | V90A | 13.2 | |||
C21855T | S98F | 6.3, 5.9, 16.4 | 1,672 | 281 | 22-03-20 | |
A21975G | D138G | 13.2 | 25 | 18 | 13-10-20 | |
T23031C | F490S | 7.0 | 100 | 50 | 05-04-20 | |
T23042C | S494P | 5.1, 5.7, 6.8 | 740 | 162 | 20-03-20 | |
C23202A | T547I | 7.8 | 87 | 20 | 07-04-20 |
The percentages of mutations found in 12 individual replicate amplicon sequences per sewage sample are presented. Results are shown for each replicate in which the mutation was detected.
Numbers and dates for clinical isolates showing the mutation are presnted. The results were obtained using the COVID-19 Genomics (COG-UK) Consortium/Mutation Explorer from sequencing data generated on 28 February 2021 (http://sars2.cvr.gla.ac.uk/cog-uk/). Variations found in more than one replicate from the same or different collection dates are underlined.